Lin Hongxia, Gebhardt Matthias, Bian Shengjie, Kwon Kyoung Ae, Shim Chang-Koo, Chung Suk-Jae, Kim Dae-Duk
College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742, South Korea.
Int J Pharm. 2007 Feb 7;330(1-2):23-31. doi: 10.1016/j.ijpharm.2006.08.043. Epub 2006 Sep 1.
The effect of various surfactants (sodium cholate, sodium taurocholate, Tween 80 and Poloxamer F68) on enhancing the transepithelial permeability of fexofenadine.HCl was evaluated in a human nasal epithelial cell monolayer model. The cytotoxicity of the surfactants on the human nasal epithelial cells was evaluated by the MTT assay. A dose-dependent reduction of cell viability was observed at higher than critical micelle concentration (CMC) of the surfactants, and the IC50 of non-ionic surfactants (Tween 80 and Poloxamer F68) was higher than that of ionic surfactants (sodium cholate and sodium taurocholate). The TEER values significantly decreased after 2 h incubation with the ionic surfactants, but were recovered after 24 h in the fresh culture media. Ionic surfactants significantly increased the transepithelial permeability (P(app)) of fexofenadine.HCl compared to the non-ionic surfactants. The reduction of TEER values upon exposing the cell monolayer to the surfactants for 2 h correlated well with the P(app) of fexofenadine.HCl, which suggests that the permeation-enhancing mechanism of the ionic surfactants is by altering the tight junction property of the paracellular pathway. F-actin staining showed that the effect of ionic surfactants on the tight junction is temporary and reversible, which is consistent with the TEER value recovery within 24 h. These results imply that ionic surfactants are potentially useful permeation enhancers for nasal delivery of hydrophilic compounds, such as fexofenadine.HCl. This study also indicated the usefulness of the human nasal epithelial cell monolayer model not only for evaluating the in vitro nasal drug transport but also for studying the mechanism and toxicity of enhancers.
在人鼻上皮细胞单层模型中评估了各种表面活性剂(胆酸钠、牛磺胆酸钠、吐温80和泊洛沙姆F68)对增强非索非那定盐酸盐经上皮渗透性的作用。通过MTT法评估表面活性剂对人鼻上皮细胞的细胞毒性。在高于表面活性剂的临界胶束浓度(CMC)时观察到细胞活力呈剂量依赖性降低,且非离子表面活性剂(吐温80和泊洛沙姆F68)的半数抑制浓度(IC50)高于离子表面活性剂(胆酸钠和牛磺胆酸钠)。与离子表面活性剂孵育2小时后,跨上皮电阻(TEER)值显著降低,但在新鲜培养基中培养24小时后恢复。与非离子表面活性剂相比,离子表面活性剂显著增加了非索非那定盐酸盐的经上皮渗透性(P(app))。将细胞单层暴露于表面活性剂2小时后TEER值的降低与非索非那定盐酸盐的P(app)密切相关,这表明离子表面活性剂的渗透增强机制是通过改变细胞旁途径的紧密连接特性。F-肌动蛋白染色显示离子表面活性剂对紧密连接的作用是暂时的且可逆的,这与24小时内TEER值的恢复一致。这些结果表明离子表面活性剂可能是用于鼻腔递送亲水性化合物(如非索非那定盐酸盐)的潜在有用的渗透增强剂。本研究还表明人鼻上皮细胞单层模型不仅可用于评估体外鼻腔药物转运,还可用于研究增强剂的作用机制和毒性。